Marc Raciti will conduct a comprehensive evaluation; this is usually is an hour-long interview. At the end of the evaluation, diagnosis and an evidence-based treatment plan will be discussed to include psychotropic medications and possible referral for therapy depending on the needs of the patient.
At the end of the intake, a follow up visit will be scheduled to monitor medications, treatment efficacy and side effects.
Studies show that Two thirds of patients will not achieve complete relief from their 1st medication. Genetic testing can help guide treatment options, minimize side effects, and maximize medication benefits to meet your individual needs.
Marc Raciti administers Genomind genetic testing to determine how a patient's genes may affect the way certain drugs will work for them. 87% of patients who have used Genomind® services have seen clinically measurable results.* Genomind has partnered or led multiple studies to support the impact of the test.
· Brennan FX et al. Prim Care Companion CNS Disord 2015: 17(2).
Genomind has processed over 250,000 samples in their laboratory. Their testing process is held to the highest standards, which is why Genomind uniquely tests every sample twice to ensure > 99% accuracy rate. Their lab is CLIA, CAP and New York State certified and exceeds the highest federal standards.
The COVID-19 Pandemic has thrown many people into a state of instability and uncertainty. Healing Wounds, offers a reasonable way to reach out to patients via telemedicine by utilizing a HIPAA compliant platform to keep the patient information secure and confidential. Treatment can be done via telemedicine or in person depending on personal preference. There is no difference in treatment or charge.
Dr. Steven Powell, MD., Board Certified Psychiatrist serves as medical director.